IP Library Patent Application 15746141
Patent Application
App. No. 15/746,141

BIODEGRADABLE SILK EAR TUBES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/746,141
Abstract

In some embodiments, the present invention provides methods for making resorbable ear tubes including the steps of providing a silk fibroin solution, and forming a silk ear tube from the silk fibroin solution, wherein the silk ear tube is less than 2 mm in length and has an outer diameter of less than 1.5 mm, and wherein the silk ear tube is resorbable. In some embodiments, the present invention also provides methods for treating otitis media including the step of introducing a silk ear tube into the ear canal of a subject, wherein the silk ear tube is less than 2 mm in length and has an outer diameter of less than 1.5 mm, and wherein the silk ear tube is resorbed by the subject.

Claims (32)

1 . A method for making resorbable ear tubes comprising

providing a silk fibroin solution; and

forming a silk ear tube from the silk fibroin solution,

wherein the silk ear tube is less than 2 mm in length and has an outer diameter of less than 1.5 mm, and wherein the silk ear tube is resorbable.

2 . The method of claim 1 , wherein the silk ear tube is formed via gel spinning or gel deposition.

3 . The method of claim 1 , wherein the silk ear tube is formed via dip coating or solution deposition.

4 . The method of claim 1 , wherein the silk ear tube is formed via micromolding.

5 . The method of claim 1 , wherein the method further comprises introducing a plurality of pores into the silk ear tube.

6 . The method of claim 5 , wherein the pores are introduced by associating a porogen with the silk fibroin solution prior to forming the silk ear tube.

7 . The method of claim 6 , wherein the porogen is selected from polyethylene oxide, NaCl, alkali metals, alkali earth metal halides, phosphates, sulfates, sugar crystals, water-soluble microspheres, polysaccharides, protein microspheres, wax particles, and synthetic polymer particles.

8 . The method of any one of claims 1 - 7 , wherein the silk ear tube comprises at least two layers.

9 . The method of claim 1 , further comprising associating at least one therapeutic agent with the silk fibroin solution prior to or during formation of the silk ear tube.

10 . The method of claim 9 , wherein the at least one therapeutic agent is selected from the group consisting of antibiotics, pain relievers, and steroids.

11 . The method of any one of claims 1 - 10 , wherein the silk fibroin solution contains between 1%-30% wt silk fibroin.

12 . The method of any one of the above claims, wherein the silk ear tube has a resorption rate of between one day and one week, inclusive.

13 . The method of any one of the above claims, wherein the silk ear tube has a resorption rate of between eight days and 2 years, inclusive.

14 . The method of any one of claims 1 - 13 , wherein the silk ear tube comprises beta-sheet content between 1-60%.

15 . The method of claim 14 , wherein the substantial beta sheet content is introduced by at least one of autoclaving, water vapor annealing and treatment with methanol.

16 . A method for treating otitis media comprising

introducing a silk ear tube into the ear canal of a subject, wherein the silk ear tube is less than 2 mm in length and has an outer diameter of less than 1.5 mm, and wherein the silk ear tube is resorbed by the subject.

17 . The method of claim 16 , further comprising administering at least one therapeutic agent to the subject prior to introduction of the silk ear tube.

18 . The method of claim 16 , further comprising administering at least one therapeutic agent to the subject subsequent to introduction of the silk ear tube.

19 . The method of claim 16 , further comprising administering at least one therapeutic agent to the subject prior substantially concurrently with introduction of the silk ear tube.

20 . The method of any one of claims 16 - 19 , wherein the at least one therapeutic agent is an antibiotic, a pain reliever, or a steroid.

21 . The method of any one of claims 16 - 20 , wherein the otitis media is acute otitis media, otitis media with effusion, or chronic suppurative otitis media.

22 . The method of any one of claims 16 - 21 , wherein the silk ear tube is resorbed over a period of time of between one day and one week, inclusive.

23 . The method of any one of claims 16 - 21 , wherein the silk ear tube is resorbed over a period of time of between eight days and 2 years, inclusive.

24 . The method of any one of claims 16 - 22 , wherein the silk ear tube comprises beta-sheet content between 1-60%.

25 . The method of claim 24 , wherein the substantial beta sheet content is introduced by at least one of autoclaving, water vapor annealing and treatment with methanol.

26 . The method of any one of claims 16 - 25 , wherein the silk ear tube comprises at least two layers.

27 . The method of claim 26 , wherein the silk ear tube comprises at least one porous layer.

28 . The method of any one of the above claims, wherein the silk fibroin is selected from the group consisting of spider silk, silkworm silk, and recombinant silk.

Assignments (4)
SECURITY INTEREST Recorded Apr 6, 2022
From: PAVMED INC.; VERIS HEALTH INC.
To: ALTO OPPORTUNITY MASTER FUND, SPC - SEGREGATED MASTER PORTFOLIO B
Reel/Frame 059620/0086 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2021
From: HARTNICK, CHRISTOPHER
To: MASSACHUSETTS EYE AND EAR INFIRMARY
Reel/Frame 054863/0328 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2021
From: KAPLAN, DAVID
To: TUFTS UNIVERSITY
Reel/Frame 054863/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2021
From: WHALEN, MICHAEL
To: THE GENERAL HOSPITAL CORPORATION - DBA MASS GENERAL HOSPITAL
Reel/Frame 054863/0368 →